2020 American Transplant Congress Archives - Page 187 of 223

ATC Virtual Congress
Live Broadcast Dates: May 30 - June 1, 2020
OnDemand Access: May 30, 2020 - June 4, 2021

Originally scheduled to take place in Philadelphia, this became a Virtual Congress due to COVID-19. For more information, visit The Official ATC Congress site.

Saturday, May 30, 2020

3:51pm-4:03pm: Addressing Critiques of the Proposed CMS Metric of Organ Procurement Organ Performance: More Data Isn’t Better

D. Goldberg¹, B. Doby², R. Lynch³

All Organs: Public Policy & Allocation • Virtual

3:51pm-4:03pm: African American Patient Perceptions of Live Kidney Donation and Educational Health Animations

R. E. Seibert¹, M. Keller², B. Dolph³, T. H. Feeley⁴, L. K. Kayler³

Kidney Living Donor: Other II • Virtual

3:51pm-4:03pm: Analyzing Causes for Death-Censored Graft Failure

M. Mayrdorfer, L. Liefeldt, N. Lachmann, W. Düttmann-Rehnolt, F. Halleck, M. G. Naik, P. Glander, K. Budde

Kidney Complications: Immune Mediated Late Graft Failure • Virtual

3:51pm-4:03pm: Antibodies to Vascular Autoantigens Are Associated with Poor Long-Term Survival of Liver Re-Transplant

Q. Xu¹, V. C. McAlister², S. Leckie², A. A. House², A. Zeevi¹

Liver Retransplantation and Other Complications • Virtual

3:51pm-4:03pm: Belatacept Provides Superior Inhibition of Donor Specific Antibody Formation in Kidney Transplant Recipients with Acute Rejection

O. Cristea, C. Larsen, I. Badell

Kidney: Acute Cellular Rejection • Virtual

3:51pm-4:03pm: Belatacept Removal by Plasmapheresis: Kinetics, Dose Adjustments and Clinical Recommendations

S. Tremblay¹, N. Wilson¹, B. Miyagawa², H. Kuzaro¹, A. R. Shields³, R. R. Alloway¹, A. Govil¹, J. Kremer⁴, E. Woodle¹, T. Mizuno², A. A. Vinks²

All Organs: Pharmacogenomics / Pharmacokinetics • Virtual

3:51pm-4:03pm: Benefits of Transplantation Over Chronic Dialysis in Septugenerian ESRD Patients with Diabetes

S. Karhadkar, A. Shaik, A. Di Carlo

Kidney Deceased Donor Selection III • Virtual

3:51pm-4:03pm: Biomarkers AFP in Combination with AFP-l3 and DCP Predicts Tumor Progression in Treatment Native HCC Patients

K. Nunez, T. Sandow, P. Thevenot, A. Cohen

Liver: Hepatocellular Carcinoma and Other Malignancies II • Virtual

3:51pm-4:03pm: Carfilzomib-Based Desensitization: Effects on HLA, Non-HLA, Auto, and Antiviral Antibodies

S. Tremblay¹, E. Portwood¹, A. R. Shields², R. R. Alloway¹, P. A. Brailey¹, E. Woodle¹

Kidney Immunosuppression: Desensitization • Virtual

3:51pm-4:03pm: Center Effects Substantially Explain Disparities in Access to Kidney Transplants, Yet DSA Effects Remain

D. Stewart, A. Robinson, D. Klassen, A. Wilk

All Organs: Disparities to Outcome and Access to Healthcare II • Virtual